Any current/future new fundraising through debt or equity?

There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript. The company highlights a strong capital base with a solvency ratio of 2.21x as of March 31, 2024, well above the regulatory requirement of 1.5x. The focus appears to be on growth through existing channels and investments in digital, agency, and group segments rather than raising fresh capital. No specific plans or comments about future debt or equity fundraising were disclosed during the call.

Any current/future capex/capital investment/strategic investment?

Star Health is investing significantly in growing its digital channels, especially the direct-to-consumer (D2C) segment, which offers the best return on equity among all channels. The company continues to invest in technology, digital, and analytics to improve customer experience and operational efficiencies. Investment in fraud analytics is ongoing to reduce claims ratios and improve claims assessment quality and network management. Expansion of agency footprint, Bancassurance, and broking channels is part of their strategy for growth. Approval received to start Gift City operations,

Future growth expectations in sales/revenue/volumes?

Expectation to grow higher than industry growth, with market projected to grow in mid-teens. Growth driven by balanced value growth (pricing) and volume growth (policy sales), targeting a 50-50 split. Expansion focus on agency channel, digital/D2C channels, Bancassurance, and group health (especially SME/MSME segment). Digital channels have shown strong fresh premium growth (~40%) and are seen as high-ROE, key to future investment. Employer-employee (group) segment grew 108% in fresh premium, with significant growth potential ahead. Strategies aim to improve market share sustainably by priorit

Future growth expectations in earnings/operating earnings/profits/EPS?

Star Health expects stronger growth and financial performance in FY '25 following a transition year in FY '24 with a new CEO and pricing actions. PAT grew 37% in FY '24; company is geared to sustain and improve profitability. Management targets growth higher than market growth rate (market expected to grow mid-teens). Focus on growth in volume and value is balanced; historically 50-50%, with FY '24 leaning more on value (price hikes). Combined ratio target to improve from 96.5% through expense and loss ratio initiatives. Agency fresh business grew 41% in Q4 FY '24; expect continued acceleratio

Star Health InsuQ4 FY24Insurance

Star Health Insu Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹572.9P/E: 32.0Market Cap: ₹33.7K CrSector: Insurance

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Expectation to grow higher than industry growth, with market projected to grow in mid-teens.
Growth driven by balanced value growth (pricing) and volume growth (policy sales), targeting a 50-50 split.
Expansion focus on agency channel, digital/D2C channels, Bancassurance, and group health (especially SME/MSME segment).
Digital channels have shown strong fresh premium growth (~40%) and are seen as high-ROE, key to future investment.
Employer-employee (group) segment grew 108% in fresh premium, with significant growth potential ahead.
Strategies aim to improve market share sustainably by prioritizing underwriting quality over growth for sake of growth.
New initiatives in technology and customer engagement expected to boost acquisition and retention.
Overall confident to sustain strong growth into FY '25 and beyond, backed by diversified channels and regulatory adaptability.

Margin guidance

Category 3

Star Health expects stronger growth and financial performance in FY '25 following a transition year in FY '24 with a new CEO and pricing actions.
PAT grew 37% in FY '24; company is geared to sustain and improve profitability.
Management targets growth higher than market growth rate (market expected to grow mid-teens).
Focus on growth in volume and value is balanced; historically 50-50%, with FY '24 leaning more on value (price hikes).
Combined ratio target to improve from 96.5% through expense and loss ratio initiatives.
Agency fresh business grew 41% in Q4 FY '24; expect continued acceleration.
Digital and Bancassurance channels expected to drive profitable growth.
Investment income yields have improved (7.7% in FY '24 vs 6.9% prior year), contributing to earnings.
ROE improved to 14.4% (IFRS basis 17.7%) with expectations to sustain or improve.

See what Star Health Insu management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no explicit mention of any current or planned new fundraising through debt or equity in the provided transcript.
The company highlights a strong capital base with a solvency ratio of 2.21x as of March 31, 2024, well above the regulatory requirement of 1.5x.
The focus appears to be on growth through existing channels and investments in digital, agency, and group segments rather than raising fresh capital.
No specific plans or comments about future debt or equity fundraising were disclosed during the call.

Order book

The transcript does not provide specific details regarding the current or expected order book or pending orders for Star Health and Allied Insurance Company Ltd. However, insights related to growth and business momentum include: - Strong growth observed in digital channels with fresh premium growth close to 40%. - Agency channel remains dominant, contributing around 82% of overall business. - Bancassurance and digital channels synergized with physical presence to expand reach including rural areas. - Corporate agency tie-ups (58 banks/NBFCs) contributing about 5% of GWP with 39%+ growth in fresh premium. - Digital fresh business growing at 34%, with 75% from own digital channels. - Employer-employee group segment fresh premiums grew by 108% FY '24. - Company gearing up for stronger growth and financial performance in FY '25 with 37% PAT growth in FY '24 and focus on underwriting quality. No explicit figures on order book or pending orders were mentioned.

See what Star Health Insu management said on order book — free account, 30 seconds.

Capex plans

Yes

Star Health is investing significantly in growing its digital channels, especially the direct-to-consumer (D2C) segment, which offers the best return on equity among all channels.
The company continues to invest in technology, digital, and analytics to improve customer experience and operational efficiencies.
Investment in fraud analytics is ongoing to reduce claims ratios and improve claims assessment quality and network management.
Expansion of agency footprint, Bancassurance, and broking channels is part of their strategy for growth.
Approval received to start Gift City operations, enabling business from NRIs and foreign countries, indicating strategic geographical expansion.
There is an increasing number of sales manager stations and physical customer touchpoints to enhance distribution reach, including semi-urban and rural India.
No explicit mention of large-scale capital expenditure, but emphasis on technology and channel investments as strategic priority areas.

Track Star Health Insu — get its next earnings analysis in your feed

How does Star Health Insu rank vs peers in Insurance?

Pro feature

ThisStar Health Insu

Rev 3Mar 3

See where Star Health Insu sits in InsuranceSee which companies these are, and every other name in the sector.Open rankings

How does Star Health Insu rank in Insurance?

Compare Star Health Insu against every Insurance company (Q4 FY24) on revenue, margins and earnings-call signals.

View Insurance leaderboard →

What Star Health Insu's management said in earlier quarters

Earlier calls (8)

Others in Insurance this season

Niva Bupa Health (Q2 FY27)
Profit after tax for H1 FY27 has risen to INR 273 crores from INR 132 crores YoY, indicating robust profitability momentum. Key concall takeaways from Niva…
Max Financial (Q2 FY27)
Partnership channels (excluding Axis) growing strongly (~19% in Q2 FY27) with new partnerships expanding the ecosystem. Key concall takeaways from Max…
Life Insurance (Q2 FY27)
Protection products are growing rapidly at over 50%, adding to the overall premium growth. Key concall takeaways from Life Insurance Corporation of India's Q2…
Go Digit General (Q2 FY27)
Go Digit is seeing growth opportunities in group health insurance, with potential to grow business by about 5% through pricing improvements. Key concall…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Star Health Insu Q4 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Star Health Insu rank in Insurance?

Continue your research

What Star Health Insu's management said in earlier quarters

Others in Insurance this season